More Than One-Third Have ED Visit Within 90 Days Before Cancer Diagnosis
By Elana Gotkine HealthDay Reporter
MONDAY, Nov. 4, 2024 -- More than one-third of patients have emergency department use within 90 days before a confirmed cancer diagnosis, according to a study published online Nov. 4 in CMAJ, the journal of the Canadian Medical Association.
Keerat Grewal, M.D., from Sinai Health at the University of Toronto, and colleagues conducted a retrospective, population-based study of patients aged 18 years or older with a confirmed cancer diagnosis from 2014 to 2021 to describe emergency department use within the 90 days before diagnosis.
The cohort included 651,071 patients with cancer, of whom 35.3 percent had an emergency department visit in the 90 days before diagnosis; of those with an emergency department visit, 51.4 percent were admitted from the emergency department. The researchers found that the likelihood of emergency department use before cancer diagnosis was increased in association with factors such as rurality (odds ratio, 1.15), residence in Northern Ontario (odds ratios, 1.14 and 1.27 for the North East and North West regions, respectively, versus Toronto), and living in the most marginalized areas (odds ratios, 1.37 and 1.09 for material resources and housing, respectively, versus least marginalized quartile). The odds of emergency department use varied significantly by cancer type, with elevated odds seen among patients with intracranial, pancreatic, liver or gallbladder, or thoracic cancer.
"We identified several patient groups that were more likely to visit the emergency department within 90 days before cancer diagnosis, including those who were older, were living in more marginalized areas, were from rural or northern areas, had comorbidities, had several types of cancer, or were diagnosed during the COVID-19 pandemic," the authors write.
One author disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-11-05 06:00
Read more
- U.K. Reports First Cluster Outside of Africa of New Mpox Variant
- Medicaid Covers GLP-1 Meds for Obesity in Just 13 States
- Clinical Practice Guideline Updated for Migraine, Tension-Type Headache
- Even at Low Levels, Arsenic in Drinking Water Could Raise Heart Risks
- USPSTF Recommends Early Screening for Syphilis in Pregnancy
- UCB Receives U.S. FDA Approval for Bimzelx (bimekizumab-bkzx) as the First IL-17A and IL-17F Inhibitor for Adults with Moderate to Severe Hidradenitis Suppurativa
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions